Appointments

  • GlaxoSmithKline Position: Non Executive Director
    Holding Balance: 3,632, appointed on 01 Jul 2016

All Deals

Declared Dealt Type EPIC Company Director Pos Shares Price Value Cur. price % Gain Gain Notes
06/02/19 06/02/19 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 355 1,495.00p £5,307 1,581.00p 5.75 £305
02/11/18 31/10/18 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 348 1,526.00p £5,310 1,581.00p 3.60 £191
25/07/18 25/07/18 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 341 1,557.00p £5,309 1,581.00p 1.54 £82
26/04/18 25/04/18 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 367 1,445.00p £5,303 1,581.00p 9.41 £499
07/02/18 07/02/18 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 416 1,278.00p £5,316 1,581.00p 23.71 £1,260
25/10/17 25/10/17 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 350 1,518.00p £5,313 1,581.00p 4.15 £220
26/07/17 26/07/17 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 449 1,599.00p £7,180 1,581.00p -1.13 -£81
27/04/17 26/04/17 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 336 1,583.00p £5,319 1,581.00p -0.13 -£7
09/02/17 08/02/17 BUY GSK GlaxoSmithKline PLC Cox, Dr... NED 342 1,555.00p £5,318 1,581.00p 1.67 £89
08/02/17 08/02/17 DRI GSK GlaxoSmithKline PLC Cox, Dr... NED 4 1,555.00p £62 1,581.00p

Transaction types:

  • BUY - Buy
  • SELL - Sell
  • EXR - Exercise
  • SEXR - Sale Post-Exercise
  • DRI - Dividend Reinvestment
  • DRIP - Dividend Reinvestment Plan
  • AWD - Award
  • TIN - Transfer In
  • TOUT - Transfer Out
  • LOF - In Lieu of Fees/Salary
  • SI - Script Issue
  • PLAC - Placing
  • RIS - Rights Issue

Director positions:

  • CEO - Chief Executive Officer
  • CH - Chairman
  • MD - Managing Director
  • FD - Financial Director
  • NED - Non Executive Director
  • ED - Executive Director
  • RES - Resigned
  • D - Director / Unknown